Sign inJoin waitlistJoin the waitlist

TB

Tomasz Beer

Physician · Oregon Health & Science University School of Medicine

Credentials: · · · ·

History

Oregon Health & Science University School of Medicine
Present

Hematology and Medical Oncology
Oregon Health & Science University
1994–1997
Internal Medicine
Oregon Health & Science University
1991–1994
Johns Hopkins School of Medicine
1987–1991

Research

Enzalutamide in metastatic prostate cancer before chemotherapy
New England Journal of Medicine · 2014 · First of 29 authors · 2,376 citations
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine · 2021 · 2,264 citations
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials…
Journal of Clinical Oncology · 2008 · 1,931 citations

MG
Mark Garzotto
53 papers
CH
Celestia Higano
48 papers
Joshi Alumkal
45 papers
Eric Small
40 papers
JG
Julie Graff
33 papers · 1 as a fellow
GT
George Thomas
31 papers
CR
Christopher Ryan
30 papers
CR
Charles Ryan
29 papers
Cora Sternberg
29 papers
Christopher Evans
27 papers
HS
Howard Scher
26 papers
Andrew Armstrong
24 papers

Grants

Resistance and Response Mechanisms to Prostate Cancer Therapy
National Cancer Institute · R01
Contact PI · $1.3M · Oregon Health & Science University
2006–2011
OHSU Knight Cancer Institute
National Cancer Institute · P30
Project lead · $177.5K · Oregon Health & Science University
2005–2010
A Novel Vitamin D Target in Human Prostate Cancer
National Cancer Institute · R21
Contact PI · $229.9K · Oregon Health & Science University
2006–2008
Acupuncture for Hot Flashes in Prostate Cancer Patients
National Cancer Institute · R21
Contact PI · $391.8K · Oregon Health & Science University
2003–2007

Clinical trials

Falcon Real World Evidence Registry
Principal investigator · Recruiting
Exact Sciences Corporation
2024–2031
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
Principal investigator · Terminated · Phase 1
OHSU Knight Cancer Institute
2013
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
Principal investigator · Terminated · Phase 2
OHSU Knight Cancer Institute
2010–2017
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Principal investigator · Terminated · Phase 3
Achieve Life Sciences
2010–2013